# FOF Capital

> FOF Capital is a VC fund in Haidian backing Medical and Biotechnology. See 20 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Haidian, China
- Total investments: 20
- Last investment: Feb 2026
- Lead investor: 5%
- Last updated: Aug 2026
- Website: http://www.fofcapital.com.cn/

FOF Capital is an investment management firm.

## Contacts

5 contacts available for FOF Capital. Shizune tracks 1 team members at FOF Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/fof-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 5 | 25% |
| Biotechnology | 4 | 20% |
| Manufacturing | 4 | 20% |
| Health Care | 3 | 15% |
| Pharmaceutical | 3 | 15% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 25% |
| Series A | 3 | 15% |
| Series B | 3 | 15% |
| Series C | 2 | 10% |
| Series D | 2 | 10% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Wang Chao | Co-Founder and Chairman | 0 | https://shizune.co/investors/profile/wang-chao-94f6 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Winglight Technology | Winglight Technology is a domestic provider of silicon photonics gyroscope chips and solutions. |  | Seed | Feb 02, 2026 |  |
| Yuanma Intelligent Pharmaceuticals | Yuanma Intelligent Pharmaceuticals is a biopharmaceutical business that focuses on circular mRNA (cmRNA) treatments, namely in vivo cmRNA CAR-T cell therapy. | $2.1M | Series A | Oct 20, 2025 |  |
| Yuanma Intelligent Pharmaceuticals | Yuanma Intelligent Pharmaceuticals is a biopharmaceutical business that focuses on circular mRNA (cmRNA) treatments, namely in vivo cmRNA CAR-T cell therapy. | $2.1M | Seed | Oct 20, 2025 |  |
| Titanium Robotics Technology | Titanium Robotics Technology specializing in the development and production of advanced robot hardware and solutions. It focuses on customized services, R&D, and production of robot hardware, aiming to create high-performance, industry standard products, develops lightweight, collaborative robots, humanoid robots, and exoskeletons, leading thesupply chain towards lightweight, miniaturization, and ease of use. |  | Seed | Jul 03, 2024 |  |
| Hengren Intelligent | Hengren Intelligent specializes in the invention, design, and selling of CD-SEM equipment. |  | Seed | Aug 14, 2023 |  |
| Dishi Medical | Dishi Medical is a company that manufactures Ophthalmic Medical Devices and other micro-assisted robots supported by biotechnology. |  | Seed | Jul 10, 2023 |  |
| uBriGene | Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization. | $21.8M | Series C | Apr 19, 2023 |  |
| Furong Biotech | Furong Bio is a developer of innovative tumor immunology drugs. | $14.7M | Series A | Feb 06, 2023 |  |
| Furong Biotech | Furong Bio is a developer of innovative tumor immunology drugs. | $14.7M | Series A | Feb 06, 2023 |  |
| uBriGene | Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization. | $14.7M | Series C | Dec 23, 2022 |  |

10 of 20 investments shown.

## Co-investors
- [Puhua Capital](https://shizune.co/investors/profile/puhua-capital) — VC Fund, 4 deals together
- [Renhe Capital](https://shizune.co/investors/profile/renhe-capital) — VC Fund, 4 deals together
- [Ainoyuan](https://shizune.co/investors/profile/ainoyuan) — VC Fund, 2 deals together
- [China Pacific Insurance](https://shizune.co/investors/profile/china-pacific-insurance) — VC Fund, 2 deals together
- [China State-Owned Capital Venture Investment Fund](https://shizune.co/investors/profile/china-state-owned-capital-venture-investment-fund) — VC Fund, 2 deals together
- [CICC](https://shizune.co/investors/profile/cicc) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does FOF Capital invest in?

FOF Capital invests primarily in Medical, Biotechnology and Manufacturing startups, most often at Seed and Series A stage. Most of the 20 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact FOF Capital?

Public channels for FOF Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at FOF Capital?

The team at FOF Capital includes Wang Chao (Co-Founder and Chairman). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co